Selected research
Industry Growth & Trends
Global Nifedipine Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Nifedipine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nifedipine Injection include Teva, Medcalo, Mylan, Pfizer, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Bayer, Pharmaoffer and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nifedipine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nifedipine Injection market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nifedipine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nifedipine Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nifedipine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nifedipine Injection Market by Company
Teva
Medcalo
Mylan
Pfizer
Cisen Pharmaceutical
Wuhan Binhu Shuanghe Pharmaceutical
Bayer
Pharmaoffer
AdvaCare
Nifedipine Injection Segment by Type
10mg/2ml
20mg/2ml
Nifedipine Injection Segment by Application
Hypertension
Angina (Chest Pain)
Nifedipine Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nifedipine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/2ml
- 20mg/2ml
Applications
- Hypertension
- Angina (Chest Pain)
Companies covered
- Teva
- Medcalo
- Mylan
- Pfizer
- Cisen Pharmaceutical
- Wuhan Binhu Shuanghe Pharmaceutical
- Bayer
- Pharmaoffer
- AdvaCare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nifedipine Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nifedipine Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Nifedipine Injection Market by Type
- 1.3.1 10mg/2ml
- 1.3.2 20mg/2ml
- 1.4 Global Nifedipine Injection Market Size by Type
- 1.4.1 Global Nifedipine Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nifedipine Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nifedipine Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nifedipine Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nifedipine Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nifedipine Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nifedipine Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nifedipine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nifedipine Injection Industry Trends
- 2.2 Nifedipine Injection Industry Drivers
- 2.3 Nifedipine Injection Industry Opportunities and Challenges
- 2.4 Nifedipine Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nifedipine Injection Revenue (2021-2026)
- 3.2 Global Top Players by Nifedipine Injection Sales (2021-2026)
- 3.3 Global Top Players by Nifedipine Injection Price (2021-2026)
- 3.4 Global Nifedipine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nifedipine Injection Major Company Production Sites & Headquarters
- 3.6 Global Nifedipine Injection Company, Product Type & Application
- 3.7 Global Nifedipine Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nifedipine Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nifedipine Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Nifedipine Injection Tier 1, Tier 2, and Tier 3
4 Nifedipine Injection Regional Status and Outlook
- 4.1 Global Nifedipine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nifedipine Injection Historic Market Size by Region
- 4.2.1 Global Nifedipine Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nifedipine Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Nifedipine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nifedipine Injection Forecasted Market Size by Region
- 4.3.1 Global Nifedipine Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nifedipine Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Nifedipine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nifedipine Injection by Application
- 5.1 Nifedipine Injection Market by Application
- 5.1.1 Hypertension
- 5.1.2 Angina (Chest Pain)
- 5.2 Global Nifedipine Injection Market Size by Application
- 5.2.1 Global Nifedipine Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nifedipine Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nifedipine Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nifedipine Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nifedipine Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nifedipine Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nifedipine Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nifedipine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Nifedipine Injection Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Medcalo
- 6.2.1 Medcalo Company Information
- 6.2.2 Medcalo Business Overview
- 6.2.3 Medcalo Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Medcalo Nifedipine Injection Product Portfolio
- 6.2.5 Medcalo Recent Developments
- 6.3 Mylan
- 6.3.1 Mylan Company Information
- 6.3.2 Mylan Business Overview
- 6.3.3 Mylan Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mylan Nifedipine Injection Product Portfolio
- 6.3.5 Mylan Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Nifedipine Injection Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Cisen Pharmaceutical
- 6.5.1 Cisen Pharmaceutical Company Information
- 6.5.2 Cisen Pharmaceutical Business Overview
- 6.5.3 Cisen Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio
- 6.5.5 Cisen Pharmaceutical Recent Developments
- 6.6 Wuhan Binhu Shuanghe Pharmaceutical
- 6.6.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information
- 6.6.2 Wuhan Binhu Shuanghe Pharmaceutical Business Overview
- 6.6.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio
- 6.6.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments
- 6.7 Bayer
- 6.7.1 Bayer Company Information
- 6.7.2 Bayer Business Overview
- 6.7.3 Bayer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Bayer Nifedipine Injection Product Portfolio
- 6.7.5 Bayer Recent Developments
- 6.8 Pharmaoffer
- 6.8.1 Pharmaoffer Company Information
- 6.8.2 Pharmaoffer Business Overview
- 6.8.3 Pharmaoffer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Pharmaoffer Nifedipine Injection Product Portfolio
- 6.8.5 Pharmaoffer Recent Developments
- 6.9 AdvaCare
- 6.9.1 AdvaCare Company Information
- 6.9.2 AdvaCare Business Overview
- 6.9.3 AdvaCare Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 AdvaCare Nifedipine Injection Product Portfolio
- 6.9.5 AdvaCare Recent Developments
7 North America by Country
- 7.1 North America Nifedipine Injection Sales by Country
- 7.1.1 North America Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nifedipine Injection Sales by Country (2021-2026)
- 7.1.3 North America Nifedipine Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Nifedipine Injection Market Size by Country
- 7.2.1 North America Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nifedipine Injection Market Size by Country (2021-2026)
- 7.2.3 North America Nifedipine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nifedipine Injection Sales by Country
- 8.1.1 Europe Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nifedipine Injection Sales by Country (2021-2026)
- 8.1.3 Europe Nifedipine Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Nifedipine Injection Market Size by Country
- 8.2.1 Europe Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nifedipine Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Nifedipine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nifedipine Injection Sales by Country
- 9.1.1 Asia-Pacific Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nifedipine Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nifedipine Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nifedipine Injection Market Size by Country
- 9.2.1 Asia-Pacific Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nifedipine Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nifedipine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nifedipine Injection Sales by Country
- 10.1.1 South America Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nifedipine Injection Sales by Country (2021-2026)
- 10.1.3 South America Nifedipine Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Nifedipine Injection Market Size by Country
- 10.2.1 South America Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nifedipine Injection Market Size by Country (2021-2026)
- 10.2.3 South America Nifedipine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nifedipine Injection Sales by Country
- 11.1.1 Middle East and Africa Nifedipine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nifedipine Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nifedipine Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nifedipine Injection Market Size by Country
- 11.2.1 Middle East and Africa Nifedipine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nifedipine Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nifedipine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nifedipine Injection Value Chain Analysis
- 12.1.1 Nifedipine Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nifedipine Injection Production Mode & Process
- 12.2 Nifedipine Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nifedipine Injection Distributors
- 12.2.3 Nifedipine Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst